Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8461920 | Annals of Anatomy - Anatomischer Anzeiger | 2011 | 7 Pages |
Abstract
The findings in the present study, suggest that the osteoclasts are the primary sites of action of zoledronate resulting in decreased osteoclastic activity, which would account for the great increase in the number and size of inactive osteoclasts resulting in marked cancellous bone formation.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cell Biology
Authors
Sarah Ralte, Kamlesh Khatri, Mahindra Nagar,